BMO Capital Maintains Outperform on Constellium, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
BMO Capital has maintained an Outperform rating on Constellium (NYSE:CSTM) but has lowered the price target from $22 to $18.
October 24, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BMO Capital has maintained an Outperform rating on Constellium but reduced the price target from $22 to $18, indicating a more cautious outlook.
The maintenance of an Outperform rating suggests continued confidence in Constellium's performance, but the lowered price target indicates a more cautious outlook, likely due to market conditions or company-specific factors. This could lead to a short-term negative impact on the stock price as investors adjust expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100